Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Theratechnologies Inc
(TSX:
TH
)
1.880
-0.050 (-2.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theratechnologies Inc
< Previous
1
2
3
Next >
Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update
April 03, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
March 14, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price
March 07, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
February 28, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
February 28, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
February 22, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Path to Resume TH1902 Clinical Development
February 16, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
February 14, 2023
From
Theratechnologies
Via
GlobeNewswire
Open Letter to Shareholders from CEO Paul Levesque
January 04, 2023
Theratechnologies Announces Fiscal Year 2023 Guidance and Operating Plan’s Key Objectives
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Update from Ongoing TH1902 Study
December 01, 2022
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,...
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays
October 26, 2022
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
October 13, 2022
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium
October 12, 2022
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population
October 03, 2022
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
July 27, 2022
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,...
From
Theratechnologies
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.